Hepatitis B and HIV-1 2019 IAS Cure Forum: lessons and benefits from interdisciplinary research.
作者信息
Paximadis M, Perez Patrigeon S, Rajasuriar R, Tatoud R, Scully E, Arbuthnot P
机构信息
Centre for HIV and STIs, Cell Biology, National Institute for Communicable Diseases and University of the Witwatersrand, Johannesburg, South Africa.
Division of Infectious Diseases, Queen's University, Kingston, Ontario, Canada.
出版信息
J Virus Erad. 2019 Nov 4;5(4):234-244. doi: 10.1016/S2055-6640(20)30027-3.
Abstract
摘要
相似文献
1
Hepatitis B and HIV-1 2019 IAS Cure Forum: lessons and benefits from interdisciplinary research.2019年国际艾滋病学会乙肝与HIV-1治愈论坛：跨学科研究的经验与益处
J Virus Erad. 2019 Nov 4;5(4):234-244. doi: 10.1016/S2055-6640(20)30027-3.
2
Converging roads: the latest science from the 2017 IAS HIV Cure and Cancer Forum.汇聚之路：2017年国际艾滋病学会（IAS）艾滋病治愈与癌症论坛的最新科学成果
J Virus Erad. 2017 Oct 1;3(4):236-241. doi: 10.1016/S2055-6640(20)30320-4.
3
Management of the Hepatitis B Virus/HIV-Coinfected Patient.乙肝病毒/艾滋病毒合并感染患者的管理
Top Antivir Med. 2015 Aug-Sep;23(3):111-4.
4
Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefits in Contrast to HIV.妊娠期丙型肝炎的治疗-权衡与 HIV 相比的风险和益处。
Curr HIV/AIDS Rep. 2018 Apr;15(2):155-161. doi: 10.1007/s11904-018-0386-z.
5
A multi-step pace towards a cure for HIV: kick, kill, and contain.向治愈艾滋病迈进的多步骤计划：踢、杀、控。
AIDS Rev. 2013 Jul-Sep;15(3):190-1.
6
For love and money: the need to rethink benefits in HIV cure studies.为了爱与金钱：在艾滋病治愈研究中重新思考益处的必要性。
J Med Ethics. 2017 Feb;43(2):96-99. doi: 10.1136/medethics-2015-103119. Epub 2016 May 18.
7
Mobilising a global response to hepatitis: Lessons learned from the HIV movement.动员全球应对肝炎：从艾滋病毒运动中吸取的经验教训。
Glob Public Health. 2018 Apr;13(4):473-488. doi: 10.1080/17441692.2016.1233989. Epub 2016 Oct 16.
8
Cure at IAS 2013.
Posit Aware. 2013 Sep-Oct;25(6):22-3.
9
Reply to Commentary: "Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?".对评论的回复：“感染艾滋病毒的参与高风险治愈相关研究的候选人在其他方面健康吗？”
J Empir Res Hum Res Ethics. 2018 Feb;13(1):23-25. doi: 10.1177/1556264617741715. Epub 2017 Nov 28.
10
The As and Bs of HIV and Hepatitis Co-Infection.HIV与丙型肝炎合并感染的要点
Trop Med Infect Dis. 2019 Mar 27;4(2):55. doi: 10.3390/tropicalmed4020055.
本文引用的文献
1
Combination of quadruplex qPCR and next-generation sequencing for qualitative and quantitative analysis of the HIV-1 latent reservoir.四联体 qPCR 与下一代测序相结合，用于 HIV-1 潜伏库的定性和定量分析。
J Exp Med. 2019 Oct 7;216(10):2253-2264. doi: 10.1084/jem.20190896. Epub 2019 Jul 26.
2
Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study.尼伏单抗联合或不联合治疗性疫苗治疗病毒抑制慢性乙型肝炎的抗 PD-1 阻断：一项初步研究。
J Hepatol. 2019 Nov;71(5):900-907. doi: 10.1016/j.jhep.2019.06.028. Epub 2019 Jul 12.
3
Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice.序贯 LASER ART 和 CRISPR 治疗消除了部分感染人源化小鼠中的 HIV-1。
Nat Commun. 2019 Jul 2;10(1):2753. doi: 10.1038/s41467-019-10366-y.
4
HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.HBV 免疫治疗：从分子机制到临床应用。
Int J Mol Sci. 2019 Jun 5;20(11):2754. doi: 10.3390/ijms20112754.
5
Development of CAR-T cells for long-term eradication and surveillance of HIV-1 reservoir.开发 CAR-T 细胞以长期清除和监测 HIV-1 储存库。
Curr Opin Virol. 2019 Oct;38:21-30. doi: 10.1016/j.coviro.2019.04.004. Epub 2019 May 25.
6
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial.VRC01 广泛中和抗体在急性 HIV 成人患者中的安全性和疗效（RV397）：一项 2 期、随机、双盲、安慰剂对照试验。
Lancet HIV. 2019 May;6(5):e297-e306. doi: 10.1016/S2352-3018(19)30053-0. Epub 2019 Apr 15.
7
A global scientific strategy to cure hepatitis B.全球治愈乙型肝炎的科学策略。
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558. doi: 10.1016/S2468-1253(19)30119-0. Epub 2019 Apr 10.
8
Safety of CD34 Hematopoietic Stem Cells and CD4 T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma.LVsh5/C46转导的CD34造血干细胞和CD4 T淋巴细胞在HIV-1感染的高危淋巴瘤患者中的安全性
Mol Ther Methods Clin Dev. 2019 Feb 26;13:303-309. doi: 10.1016/j.omtm.2019.02.006. eCollection 2019 Jun 14.
9
HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles.乙肝病毒和艾滋病毒/乙肝病毒合并感染患者具有不同的免疫耗竭和凋亡血清生物标志物谱。
Pathog Immun. 2019;4(1):39-65. doi: 10.20411/pai.v4i1.267. Epub 2019 Feb 13.
10
Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.单细胞刻画和定量分析治疗和未治疗 HIV 感染中具有翻译能力的病毒储存库。
PLoS Pathog. 2019 Feb 27;15(2):e1007619. doi: 10.1371/journal.ppat.1007619. eCollection 2019 Feb.
Zotero 插件